查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830500

男性健康診斷市場（按產品類型、最終用戶和應用）—全球預測 2025-2032

Mens Health Diagnostics Market by Product Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，男性健康診斷市場將成長 353.9 億美元，複合年成長率為 11.70%。

主要市場統計數據
基準年2024年 145.9億美元
預計2025年 162.7億美元
預測年份：2032年 353.9億美元
複合年成長率（%） 11.70%

男性健康診斷的當代概況，展示了臨床需求、監管嚴謹性和技術的融合如何再形成開發和交付

現代男性健康診斷領域由臨床需求、技術創新和不斷發展的護理途徑的融合所定義。消費者和臨床醫生越來越要求診斷方法侵入性更小、更特異性，並且與慢性病管理更加緊密地結合。同時，監管審查和付款方的期望也提高了臨床檢驗、真實世界績效證據和成本效益的標準。這些趨勢迫使製造商、實驗室網路和醫療系統重新評估其產品開發時間表和商業化策略。

相關人員正在逐漸擺脫傳統的診斷模式，轉而投資於將影像學方法與分子和基因檢測結合的混合模式，以獲得更豐富的診斷訊號。跨醫療環境的整合正在加速，重點是連接門診和醫院的工作流程，並將及時的診斷數據轉化為治療決策。因此，策略制定者必須在短期營運壓力與互通性、數據分析和證據生成方面的長期投資之間取得平衡，以保持競爭優勢並支持報銷途徑。

技術、臨床效用預期和醫療保健提供模式的重大系統轉變正在從根本上改變診斷創新和採用

多項變革性變革正在重塑男性健康診斷的設計、檢驗和在醫療環境中的部署方式。精準技術正從概念驗證邁向常規臨床應用，從而能夠針對前列腺疾病和心血管風險等疾病進行更有針對性的篩檢和監測。同時，影像學技術也在不斷發展，軟體功能增強、人工智慧解讀和跨模態整合等技術不斷進步，在提高診斷準確性的同時，也支援更有效率的工作流程。

另一個重要的曲折點是價值導向醫療原則的興起，該原則優先考慮療效和長期成本規避。這迫使診斷研發人員不僅要證明分析的有效性，還要證明臨床效用和路徑層面的影響。此外，商業化格局也在改變。製造商、實驗室和醫療系統之間的策略夥伴關係對於擴大應用範圍和獲得有利的報銷條件至關重要。總而言之，這些因素為創新者提供了機會和義務，以建立可靠的臨床證據，促進臨床醫生的認可，並使診斷技術與不斷發展的醫療獎勵保持一致。

不斷變化的關稅政策和貿易措施如何使整個診斷價值鏈的採購、定價策略和供應商足跡決策變得複雜

新關稅及相關貿易政策的實施將進一步增加診斷供應鏈中供應商、製造商和服務供應商的營運複雜性。資本密集診斷影像系統和專用檢測試劑的進口成本增加，可能會改變醫院和診斷中心的採購決策，影響升級週期和資本配置。面臨跨境成本上升的供應商可能需要重新評估其區域製造佈局、協商新的供應商條款或本地化零件，以緩解利潤率下滑的影響。

這些政策變化也將影響定價策略和合約談判，因為最終用戶的預算有限，並且對整體擁有成本非常敏感。因此，那些積極模擬關稅影響並與採購、臨床營運和財務部門相關人員合作的機構，將更有能力維持對先進診斷技術的使用。此外，對成本促進因素透明度的需求日益成長，這可能會促使一些供應商提供其他商業結構，例如託管服務、試劑租賃和基於績效的契約，以緩解預算壓力並保持應用勢頭。

可操作的細分洞察，將產品模式、醫療保健環境和臨床應用與策略發展和商業化重點連結起來

精細的細分視角清晰地展現了創新和應用壓力最大的領域。在評估產品類型時，電腦斷層掃描、磁振造影造影、核醫造影、超音波和X光等影像方式各自發揮獨特的診斷作用，而影像系統對於結構和功能評估仍然至關重要。與影像技術同時進行的實驗室檢測，透過生物標記檢測和基因檢測，增加了分子層面的深度，從而實現更早的檢測和個人化的疾病評估。這些產品組合共同構成了互補的診斷途徑，如果能有效地整合到各個護理團隊中，就能增強臨床決策能力。

從最終用戶的觀點來看，醫療保健環境在工作流程要求和資本密集度方面差異很大。門診手術中心、診所、診斷中心和醫院都需要根據其處理量、人員配置模式和報銷方案量身定做的解決方案。應用也同樣多樣化，臨床和商業性重點關注心血管診斷、糖尿病監測、前列腺癌診斷和泌尿系統疾病診斷，這些領域尚未滿足的需求和既定的護理通訊協定為提供可行洞察的工具創造了多樣化的機會。了解每個垂直領域的獨特促進因素，可以支援有針對性的開發、證據生成和商業化計劃，使產品功能與每個環境和用例的實際情況保持一致。

區域動態和差異化的市場現實將決定美洲、中東和非洲以及亞太地區診斷策略的應用

區域動態決定了需求模式和臨床應用路徑。在美洲，整合的醫療系統和統一的實驗室網路為能夠展現可衡量的路徑改進並符合付款人期望的解決方案創造了肥沃的土壤。相較之下，歐洲、中東和非洲的監管環境和報銷機制各不相同，需要採取適應性的市場推廣方式和針對特定區域的證據策略。同時，亞太地區的特點是基礎設施快速擴張，並專注於國內製造和區域分銷網路，這影響了採購偏好和合作模式。

這些地域差異也會影響臨床實務規範、影像能力投資以及新型檢測方法的規模化速度。因此，企業必須根據當地實際情況，量身定做監管計劃、證據生成和商業性夥伴關係。利用當地臨床領導企業，投資特定地區的健康經濟證據，並調整服務交付​​模式，可加速技術應用，並確保創新轉化為跨市場的永續臨床和經濟價值。

透過技術整合、證據產生和附加價值服務來定義診斷領導力的策略競爭行動和能力

男性健康診斷領域的競爭優勢日益取決於能否將技術優勢與強力的臨床證據和可擴展的服務模式結合。領先的開發商正在強調硬體和軟體的協同效應，並開發可與分析和決策支援工具互通的成像平台，以減少解讀的差異性並增強臨床醫生的信心。同時，投資於高度特異性生物標記檢測和基因平台的公司正透過宣稱其能夠實現更早的檢測並提高預後準確性來脫穎而出。

此外，成功的公司正在將其價值提案從產品服務擴展到實施支援、培訓和結果衡量。這種轉變反映出人們意識到，僅僅銷售診斷產品而缺乏相關的變革管理，無法推動臨床應用。與檢測服務提供者和醫療系統建立策略合作夥伴關係可以擴大覆蓋範圍，同時減輕證據產生的負擔。因此，那些將卓越技術與務實的商業化策略和真實性能數據相結合的公司，將在競爭激烈、以證據主導的市場中佔據有利地位。

實際的策略舉措，幫助製造商和醫療保健提供者加速採用，證明臨床效用，並在政策轉變中保護商業性彈性

為了將新興趨勢轉化為永續優勢，產業領導者應優先考慮三項策略性舉措。首先，透過投資嚴格的臨床檢驗項目，將診斷結果與治療決策和患者預後明確關聯，解決付款方顧慮，並推動跨護理路徑的採用。其次，透過靈活的資金籌措、配套服務或結果導向合約（這些合約可以分擔實施風險並體現路徑層面的價值）來重組商業模式，降低採用門檻。這些措施將為醫療系統購買者和付款方創造更清晰的決策點。

第三，深化整個生態系統的夥伴關係，與學術中心、社區醫院和診斷實驗室合作，加速真實世界證據收集，並建立可複製的工作流程。透過協調這些要素，組織可以縮短價值實現時間，並培養臨床醫生的擁護者。最後，保持靈活的供應鏈和監管策略，快速回應政策變化和關稅相關的中斷，以保障供應的連續性並保持具有競爭力的價格。這些綜合措施可以增強市場韌性，並提高長期應用的可能性。

採用穩健的混合方法研究途徑，結合相關人員訪談、臨床文獻綜述、政策分析和情境檢驗來驗證見解

本研究整合了主要相關人員訪談、同行評審臨床文獻的系統性綜述以及對監管和付款方政策發展的分析，以確保觀點的平衡性和主導。主要訪談對象包括臨床醫生、實驗室主任、技術負責人和採購專家，以了解營運現況和應用障礙。次要分析重點在於近期發表的臨床試驗、指南更新和調查方法論文，以檢驗該技術的臨床有效性及其在護理路徑中的潛在效用。

此外，我們考察了公共變化和採購框架，以評估其對資本設備和耗材的影響。數據合成強調跨來源交叉檢驗，以減輕單一來源偏差並突出一致的主題。最後，我們透過情境規劃對我們的研究結果進行了壓力測試，以考慮貿易政策、報銷環境和臨床實踐的變化如何影響開發商和醫療保健提供者的策略重點和營運決策。

診斷趨勢總結，強調模式整合、證據需求增加以及強勁的商業化途徑以產生持續影響

總而言之，男性健康診斷領域正處於一個關鍵的十字路口，技術成熟度、支付方審查以及醫療服務模式的轉變正在交匯，從而重新調整創新者和提供者的優先事項。影像學和實驗室檢測日益互補，為早期發現和更個人化的疾病管理創造了途徑。同時，對臨床效用和途徑層面證據的需求日益成長，促使人們重新評估商業化策略和夥伴關係模式，以確保臨床醫生的接受度和支付方的覆蓋範圍。

展望未來，積極建立整合解決方案、優先考慮透明證據開發並根據預算實際情況調整商業結構的組織將最有可能獲得臨床和經濟價值。應對關稅和政策阻力需要周密的供應鏈規劃和靈活的合約方式。透過將技術能力與現實證據和商業化策略相結合，相關人員可以加速診斷護理的有意義的改進，同時建立具有韌性的經營模式。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 採用人工智慧驅動的家用睪固酮和前列腺癌檢測套組進行即時健康監測的人數正在增加
  • 個人化荷爾蒙分析平台越來越受歡迎，這些平台能夠為男性健康提供客製化的見解和治療建議
  • 透過遠距泌尿系統諮詢和診斷的遠端醫療整合激增，提高了男性醫療保健的可近性。
  • 擴展非侵入性液態生物檢體技術以動態監測前列腺癌和睪丸癌的進展
  • 基於行動應用程式的生育測試與穿戴式數據相結合以支持延遲生育計劃的需求正在上升
  • 監管變化擴大了男性高級代謝和心血管診斷測試的保險覆蓋範圍

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章男性健康診斷市場（依產品類型）

  • 影像系統
    • 電腦斷層掃描
    • 磁振造影
    • 核子造影
    • 超音波
    • X光
  • 實驗室檢查
    • 生物標記檢測
    • 基因檢測

第9章男性健康診斷市場（按最終用戶）

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第 10 章男性健康診斷市場（按應用）

  • 心血管診斷
  • 糖尿病監測
  • 前列腺癌診斷
  • 泌尿系統疾病的診斷

第11章男性健康診斷市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章男性健康診斷市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 男性健康診斷市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Sysmex Corporation
    • bioMerieux SA
    • Becton Dickinson and Company
    • QIAGEN NV
    • DiaSorin SpA
Product Code: MRR-431388EE3BC2

The Mens Health Diagnostics Market is projected to grow by USD 35.39 billion at a CAGR of 11.70% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.59 billion
Estimated Year [2025] USD 16.27 billion
Forecast Year [2032] USD 35.39 billion
CAGR (%) 11.70%

A contemporary overview of mens health diagnostics showing how clinical demand, regulatory rigor, and technology convergence are reshaping development and delivery

The modern mens health diagnostics landscape is defined by the convergence of clinical need, technological innovation, and evolving care pathways. Consumers and clinicians increasingly demand diagnostic approaches that are less invasive, more specific, and better integrated with chronic disease management. At the same time, regulatory scrutiny and payer expectations are raising the bar for clinical validation, real-world performance evidence, and cost-effectiveness. These dynamics are prompting manufacturers, laboratory networks, and health systems to rethink product development timelines and commercialization strategies.

Transitioning from legacy diagnostic paradigms, stakeholders are investing in hybrid models that combine imaging modalities with molecular and genetic assays to produce richer diagnostic signals. Integration across care settings is accelerating, with a focus on connecting ambulatory and hospital workflows to deliver timely diagnostic data into treatment decisions. Consequently, strategic planners must balance near-term operational pressures with longer-term investments in interoperability, data analytics, and evidence generation to sustain competitive differentiation and support reimbursement pathways.

Key systemic shifts in technology, clinical utility expectations, and care delivery models that are fundamentally altering diagnostics innovation and adoption

Several transformative shifts are reshaping how mens health diagnostics are designed, validated, and deployed across care settings. Precision technologies have moved beyond proof of concept to routine clinical application, enabling more targeted screening and monitoring approaches for conditions such as prostate disease and cardiovascular risk. Concurrently, imaging has evolved through enhanced software, AI-assisted interpretation, and cross-modality integration that boosts diagnostic accuracy while supporting workflow efficiency.

Another major inflection point is the elevation of value-based care principles, which prioritizes outcomes and long-term cost avoidance. This forces diagnostic developers to demonstrate not just analytic validity, but clinical utility and pathway-level impact. Moreover, the commercialization environment is changing; strategic partnerships between manufacturers, labs, and health systems are becoming essential to scale adoption and secure favorable reimbursement. Taken together, these forces create both opportunities and obligations for innovators to produce robust clinical evidence, drive clinician acceptance, and align diagnostics with evolving care incentives.

How evolving tariff policies and trade measures are complicating procurement, pricing strategies, and supplier footprint decisions across the diagnostics value chain

The introduction of new tariff measures and related trade policies creates an added layer of operational complexity for suppliers, manufacturers, and service providers in the diagnostics supply chain. Increased import costs for capital-intensive imaging systems and specialized assay reagents can alter procurement decisions at hospitals and diagnostic centers, influencing upgrade cycles and capital allocation. Suppliers facing higher cross-border costs may need to reassess regional manufacturing footprints, negotiate new supplier terms, or localize components to mitigate margin erosion.

These policy changes also affect pricing strategies and contract negotiations, because end users operate under constrained budgets and are sensitive to total cost of ownership. As a result, organizations that proactively model tariff impacts and engage stakeholders across procurement, clinical operations, and finance can better preserve access to advanced diagnostics. Furthermore, the need for transparency around cost drivers will intensify, prompting some vendors to offer alternative commercial structures such as managed services, reagent rental, or outcome-based contracting to ease budgetary pressures and maintain adoption momentum.

Actionable segmentation insights linking product modalities, care settings, and clinical applications to strategic development and commercialization priorities

A granular segmentation lens clarifies where innovation and adoption pressures are most acute. When evaluating product types, imaging systems remain critical for structural and functional assessment, with modalities including computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray each serving distinct diagnostic roles. Parallel to imaging, laboratory tests add molecular depth through biomarker assays and genetic testing, enabling earlier detection and more personalized disease characterization. Together, these product classes form complementary diagnostic pathways that bolster clinical decision-making when integrated effectively across care teams.

From an end-user perspective, care settings differ substantially in workflow requirements and capital intensity. Ambulatory surgical centers, clinics, diagnostic centers, and hospitals each demand tailored solutions that address throughput, staffing models, and reimbursement layouts. Applications likewise concentrate clinical and commercial focus on cardiovascular diagnostics, diabetes monitoring, prostate cancer diagnostics, and urological disorder diagnostics, where unmet needs and established care protocols create varied opportunities for tools that deliver actionable insights. Understanding these segment-specific drivers supports targeted development, evidence generation, and commercialization plans that align product capabilities to the realities of each setting and use case.

Regional dynamics and differentiated market realities that determine how diagnostics strategies must adapt across the Americas, Europe/Middle East/Africa, and Asia-Pacific

Regional dynamics shape both demand patterns and the pathway to clinical adoption. In the Americas, integrated health systems and consolidated laboratory networks create fertile ground for solutions that demonstrate measurable pathway improvements and align with payer expectations. In contrast, Europe, the Middle East & Africa presents a heterogeneous landscape where diverse regulatory frameworks and reimbursement mechanisms require adaptable go-to-market approaches and localized evidence strategies. Meanwhile, Asia-Pacific is characterized by rapid infrastructure expansion and a strong emphasis on domestic manufacturing and regional distribution networks, which influences procurement preferences and partnership models.

These geographic distinctions also influence clinical practice norms, investment in imaging capabilities, and the scale-up speed for novel assays. Therefore, companies should tailor regulatory planning, evidence generation, and commercial partnerships to regional realities. Leveraging local clinical champions, investing in region-specific health economics evidence, and adapting service delivery models can accelerate adoption and ensure that innovations translate into sustainable clinical and financial value across markets.

Strategic competitive behaviors and capabilities that define leadership in diagnostics through technology integration, evidence generation, and value-added services

Competitive positioning in mens health diagnostics increasingly depends on the ability to integrate technological strengths with robust clinical evidence and scalable service models. Leading organizations emphasize hardware-software synergy, developing imaging platforms that interoperate with analytics and decision-support tools to reduce interpretation variability and enhance clinician confidence. At the same time, companies investing in high-specificity biomarker assays and genetic platforms are differentiating through claims of earlier detection and greater prognostic precision.

Moreover, successful players are extending their value propositions beyond product delivery to include implementation support, training, and outcomes measurement. This shift reflects the recognition that selling a diagnostic without the associated change management is unlikely to drive widespread clinical uptake. Strategic alliances with laboratory service providers and health systems can amplify reach while easing the burden of evidence generation. Consequently, firms that combine technological excellence with pragmatic commercialization tactics and real-world performance data position themselves favorably in a competitive and evidence-driven marketplace.

Practical strategic initiatives for manufacturers and providers to accelerate adoption, prove clinical utility, and safeguard commercial resilience amid policy shifts

Industry leaders should prioritize a trio of strategic moves to translate emerging trends into durable advantage. First, invest in rigorous clinical validation programs that explicitly tie diagnostic outputs to treatment decisions and patient outcomes, thereby addressing payer concerns and facilitating adoption across care pathways. Second, restructure commercial models to lower adoption barriers through flexible financing, bundled service offerings, or outcome-aligned contracts that share implementation risk and demonstrate pathway-level value. These initiatives will create clearer decision points for health system purchasers and payers.

Third, deepen partnerships across the ecosystem, engaging academic centers, community hospitals, and diagnostic laboratories to accelerate real-world evidence collection and to create reproducible workflows. By coordinating these elements, organizations can shorten time-to-value and foster clinician champions. Finally, maintain an agile supply chain and regulatory strategy to respond quickly to policy shifts and tariff-related disruptions, safeguarding continuity of supply and preserving competitive pricing. Together, these measures will strengthen market resilience and enhance the probability of long-term adoption.

Robust mixed-methods research approach combining stakeholder interviews, clinical literature review, policy analysis, and scenario testing to validate insights

This research synthesizes primary stakeholder interviews, systematic review of peer-reviewed clinical literature, and an analysis of regulatory and payer policy developments to ensure a balanced and evidence-driven perspective. Primary interviews included clinicians, laboratory directors, technology leaders, and procurement specialists to capture operational realities and adoption barriers. Secondary analysis focused on recently published clinical trials, guideline updates, and methodology papers to triangulate the technologies' clinical validity and potential utility within care pathways.

In addition, the methodology incorporated a review of public policy changes and procurement frameworks to assess their implications for capital equipment and consumables. Data synthesis emphasized cross-validation across sources to mitigate single-source bias and to surface consistent themes. Finally, findings were stress-tested through scenario planning to examine how shifts in trade policies, reimbursement environments, and clinical practice might influence strategic priorities and operational decisions for developers and providers.

Conclusive synthesis of diagnostics trends highlighting integration of modalities, elevated evidence requirements, and resilient commercialization pathways for sustained impact

In sum, the mens health diagnostics arena is at a pivotal juncture where technological maturation, payer scrutiny, and shifting care delivery models converge to reshape priorities for innovators and providers. Imaging modalities and laboratory assays are increasingly complementary, creating pathways for earlier detection and more personalized disease management. At the same time, heightened requirements for clinical utility and pathway-level evidence are prompting a reassessment of commercialization strategies and partnership models to secure clinician acceptance and payer coverage.

Looking forward, organizations that proactively build integrated solutions, prioritize transparent evidence development, and adapt commercial structures to meet budgetary realities will be best positioned to capture clinical and economic value. Navigating tariff and policy headwinds requires deliberate supply chain planning and flexible contracting approaches. By aligning technological capabilities with pragmatic evidence and commercialization tactics, stakeholders can accelerate meaningful improvements in diagnostic care while building resilient business models.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of AI-driven at-home testosterone and prostate cancer screening kits allowing real-time health monitoring
  • 5.2. Rising popularity of personalized hormone profiling platforms offering tailored male wellness insights and treatment recommendations
  • 5.3. Surge in telehealth integration with remote urology consults and diagnostics for improved accessibility in men's health care
  • 5.4. Expansion of noninvasive liquid biopsy technologies for dynamic monitoring of prostate and testicular cancer progression
  • 5.5. Increased demand for mobile app-based fertility testing combined with wearable data to support delayed fatherhood planning
  • 5.6. Regulatory changes driving broader insurance coverage for advanced metabolic and cardiovascular diagnostic tests in men

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mens Health Diagnostics Market, by Product Type

  • 8.1. Imaging Systems
    • 8.1.1. Computed Tomography
    • 8.1.2. Magnetic Resonance Imaging
    • 8.1.3. Nuclear Imaging
    • 8.1.4. Ultrasound
    • 8.1.5. X Ray
  • 8.2. Laboratory Tests
    • 8.2.1. Biomarker Assays
    • 8.2.2. Genetic Testing

9. Mens Health Diagnostics Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Mens Health Diagnostics Market, by Application

  • 10.1. Cardiovascular Diagnostics
  • 10.2. Diabetes Monitoring
  • 10.3. Prostate Cancer Diagnostics
  • 10.4. Urological Disorder Diagnostics

11. Mens Health Diagnostics Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Mens Health Diagnostics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Mens Health Diagnostics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. F. Hoffmann-La Roche Ltd
    • 14.3.2. Abbott Laboratories
    • 14.3.3. Thermo Fisher Scientific Inc.
    • 14.3.4. Danaher Corporation
    • 14.3.5. Siemens Healthineers AG
    • 14.3.6. Sysmex Corporation
    • 14.3.7. bioMerieux SA
    • 14.3.8. Becton Dickinson and Company
    • 14.3.9. QIAGEN N.V.
    • 14.3.10. DiaSorin S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 234. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 235. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 236. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 237. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 272. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 273. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 282. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 283. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 284. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 285. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 295. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 304. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 305. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 306. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 307. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 314. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 315. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2024 (USD MILLION)
  • TABLE 316. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2025-2032 (USD MILLION)
  • TABLE 317. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. BRAZIL MENS HEA